JP Morgan Call 45 PRLB 18.10.2024/ DE000JB9XYS2 /
24.05.2024 08:30:13 | Diff.- | Geld09:52:49 | Brief09:52:49 | Basiswert | Basispreis | Fälligkeit | Optionsart |
---|---|---|---|---|---|---|---|
0,073EUR | - | 0,070 Geld Vol: 3.000 |
0,270 Brief Vol: 3.000 |
Proto Labs Inc | 45,00 USD | 18.10.2024 | Call |
GlobeNewswire
11:00
Helsinn and Angelini Pharma sign a partnership agreement renewal to commercialize AULIN® and MESULID...
GlobeNewswire
10:30
REPEAT - Metasphere Labs Announces Development of Innovative Carbon Credit Protocol for Grid-Scale B...
GlobeNewswire
10:00
Samsung Bioepis Announces Oral Presentation on Switching Period Results for SB16, a Proposed Biosimi...
GlobeNewswire
10:00
TDOC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Teladoc Health, Inc. Investors...
GlobeNewswire
10:00
GDRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GoodRx Holdings, Inc. Investor...
GlobeNewswire
10:00
SHCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sharecare Inc. Investors with ...
GlobeNewswire
10:00
VFS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that VinFast Auto Ltd. (f/k/a Black ...
GlobeNewswire
10:00
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Sub...
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite